Neonatal Research Institute at Sharp Mary Birch Hospital for Women & Newborns
The Neonatal Research Institute (NRI) at Sharp Mary Birch Hospital for Women & Newborns was established in August 2013 to identify and disseminate the latest evidence-based practices for newborn care. The NRI's mission is to improve outcomes for premature and at-risk infants through research and cutting-edge therapies at the very beginning of their lives so that they will be healthier throughout their child- and adulthoods.
The discoveries happening at Sharp Mary Birch have the potential to impact outcomes for newborns both regionally and nationwide—ultimately improving overall health for future generations.
This vast potential impact has drawn support from the prestigious National Institutes of Health (NIH) for cord blood delivery and delayed cord clamping studies, which contributed to the more than $1 million raised to transform care for newborns at the institute in the NRI's first year.
In 2015, $662,719 was distributed by Sharp HealthCare Foundation to support the NRI's research of innovative therapies that can improve the long-term health of at-risk infants.
The institute's goal is to perform 10 trials per year that impact at least 200 newborns and their families. We are committed to building a $5 million endowment to make this possible.
Below are some specific ways you can support the groundbreaking research of the NRI:
A gift of $100 can purchase of a single brain monitoring sensor which uses light waves to determine a newborn's oxygen levels and help determine whether therapies have effectively protected the brain. Gifts in the range of $100 to $500 are also instrumental in supporting ongoing community education and outreach around the NRI and its studies.
A gift of $1,000 can cover the enrollment of one at-risk newborn in a research trial, including therapy as well as navigation and support services for the patient's family.
Gifts between $10,000 and $25,000 can fund the establishment of a new research study, including initiation of a pilot study with 20-30 newborns to determine if there is potential for benefit on a larger scale. Learn more about studies recently funded by donor support.
Give now to support innovative research to improve outcomes for our tiniest patients.